Related Experiment Video
Updated: Jun 5, 2025

Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy
Published on: April 29, 2014
Renal cell carcinoma with succinate dehydrogenase A mutation: A case report and literature review
Min Hu1, Xiao-Tong Wang2, Xue-Xue Xiao1
1Department of Pathology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430079, P.R. China.
Abstract:
Succinate dehydrogenase (SDH)-deficient renal cell carcinoma (RCC) is a rare subtype of RCC characterized by the presence of a germline mutation in one of the four subunits of the SDH enzyme complex (SDHA, SDHB, SDHC and SDHD). Together with a somatic second hit, these variants lead to the loss of function of the SDH complex. SDH-deficient RCC associated with SDHA mutation is a rare condition; to the best of our knowledge, there have been only four patients reported in the literature. The present study describes the case of a 22-year-old female patient with RCC associated with SDHA gene mutation. Next-generation sequencing and Sanger sequencing identified a novel heterozygous frameshift variant (NM_004168.4: c.992_999dup) in the SDHA gene. In the literature, this mutation has not previously been reported to be associated with RCC. The present description of a patient with a heterozygous SDHA frameshift variant expands the phenotypic spectrum of the SDHA gene, and provides further clinical, morphological and molecular data of SDHA-deficient RCC.
Insights
Succinate dehydrogenase (SDH)-deficient renal cell carcinoma (RCC) is rare. This study details a novel SDHA gene mutation in a young female patient, expanding knowledge of SDH-deficient RCC.
Area of Science:
- Oncology
- Genetics
Background:
- Succinate dehydrogenase (SDH)-deficient renal cell carcinoma (RCC) is a rare subtype characterized by germline mutations in SDH enzyme subunits.
- Loss of SDH function, crucial for cellular respiration, results from these mutations combined with a somatic second hit.
Observation:
- This report describes a 22-year-old female patient diagnosed with RCC associated with a germline SDHA gene mutation.
- Genetic analysis revealed a novel heterozygous frameshift variant (c.992_999dup) in the SDHA gene, previously unreported in RCC.
Findings:
- The identified SDHA mutation is novel and has not been previously linked to renal cell carcinoma in existing literature.
- This case represents one of the few documented instances of SDH-deficient RCC specifically associated with an SDHA mutation.
Implications:
- The findings expand the known phenotypic spectrum associated with SDHA gene variants.
- This case provides valuable clinical, morphological, and molecular data for understanding SDH-deficient RCC and its genetic basis.
More Related Videos
06:38A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...